Natural Phytochemicals in Bladder Cancer Prevention and Therapy
- PMID: 33996570
- PMCID: PMC8120318
- DOI: 10.3389/fonc.2021.652033
Natural Phytochemicals in Bladder Cancer Prevention and Therapy
Abstract
Phytochemicals are natural small-molecule compounds derived from plants that have attracted attention for their anticancer activities. Some phytochemicals have been developed as first-line anticancer drugs, such as paclitaxel and vincristine. In addition, several phytochemicals show good tumor suppression functions in various cancer types. Bladder cancer is a malignant tumor of the urinary system. To date, few specific phytochemicals have been used for bladder cancer therapy, although many have been studied in bladder cancer cells and mouse models. Therefore, it is important to collate and summarize the available information on the role of phytochemicals in the prevention and treatment of bladder cancer. In this review, we summarize the effects of several phytochemicals including flavonoids, steroids, nitrogen compounds, and aromatic substances with anticancer properties and classify the mechanism of action of phytochemicals in bladder cancer. This review will contribute to facilitating the development of new anticancer drugs and strategies for the treatment of bladder cancer using phytochemicals.
Keywords: apoptosis; bladder cancer; cell cycle; phytochemical; proliferation.
Copyright © 2021 Xia, Chen, Lu, Li, Lian, Kang and Jung.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.Front Pharmacol. 2020 Jan 28;10:1614. doi: 10.3389/fphar.2019.01614. eCollection 2019. Front Pharmacol. 2020. PMID: 32116665 Free PMC article. Review.
-
Anticancer applications of phytochemicals in gastric cancer: Effects and molecular mechanism.Front Pharmacol. 2023 Jan 12;13:1078090. doi: 10.3389/fphar.2022.1078090. eCollection 2022. Front Pharmacol. 2023. PMID: 36712679 Free PMC article. Review.
-
Plant derived anticancer agents: A green approach towards skin cancers.Biomed Pharmacother. 2018 Jul;103:1643-1651. doi: 10.1016/j.biopha.2018.04.113. Epub 2018 May 7. Biomed Pharmacother. 2018. PMID: 29864953 Review.
-
Novel Phytochemical Constituents and Anticancer Activities of the Genus, Typhonium.Curr Drug Metab. 2019;20(12):946-957. doi: 10.2174/1389200220666191118102616. Curr Drug Metab. 2019. PMID: 31744445 Review.
-
Prospects of compounds of herbal plants as anticancer agents: a comprehensive review from molecular pathways.Front Pharmacol. 2024 Jul 22;15:1387866. doi: 10.3389/fphar.2024.1387866. eCollection 2024. Front Pharmacol. 2024. PMID: 39104398 Free PMC article. Review.
Cited by
-
Electrospun Food Polysaccharides Loaded with Bioactive Compounds: Fabrication, Release, and Applications.Polymers (Basel). 2023 May 16;15(10):2318. doi: 10.3390/polym15102318. Polymers (Basel). 2023. PMID: 37242893 Free PMC article. Review.
-
Phytochemicals as Chemo-Preventive and Therapeutic Agents Against Bladder Cancer: A Comprehensive Review.Diseases. 2025 Mar 30;13(4):103. doi: 10.3390/diseases13040103. Diseases. 2025. PMID: 40277814 Free PMC article. Review.
-
Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG-Study on Stability and Anticancer Potential.Nanomaterials (Basel). 2022 Apr 8;12(8):1274. doi: 10.3390/nano12081274. Nanomaterials (Basel). 2022. PMID: 35457986 Free PMC article.
-
A Novel Approach for Bladder Cancer Treatment: Nanoparticles as a Drug Delivery System.Int J Nanomedicine. 2024 Dec 17;19:13461-13483. doi: 10.2147/IJN.S498729. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39713223 Free PMC article. Review.
-
Natural anti-cancer products: insights from herbal medicine.Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y. Chin Med. 2025. PMID: 40490812 Free PMC article. Review.
References
-
- Paz-Ares LG, Solsona E, Esteban E, Saez A, Gonzalez-Larriba J, Anton A, et al. . Randomized Phase III Trial Comparing Adjuvant Paclitaxel/Gemcitabine/Cisplatin (PGC) to Observation in Patients With Resected Invasive Bladder Cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 Study. J Clin Oncol (2010) 28(18):LBA4518. 10.1200/jco.2010.28.18_suppl.lba4518 - DOI
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources